Limited value of the international staging system for predicting long-term outcome of transplant-ineligible, newly diagnosed, symptomatic multiple myeloma in the era of novel agents.
Kuroda J, Shimura Y, Ohta K, Tanaka H, Shibayama H, Kosugi S, Fuchida S, Kobayashi M, Kaneko H, Uoshima N, Ishii K, Nomura S, Taniwaki M, Takaori-Kondo A, Shimazaki C, Tsudo M, Hino M, Matsumura I, Kanakura Y; Kansai Myeloma Forum Investigators.
Kuroda J, et al.
Int J Hematol. 2014 Apr;99(4):441-9. doi: 10.1007/s12185-014-1539-5. Epub 2014 Mar 1.
Int J Hematol. 2014.
PMID: 24584872